Koninklijke Philips N.V.

PHG Healthcare Medical Devices

Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024. In the quarter to June 2026, revenue grew 2.94%, EPS grew 56.7%, free cash flow grew 49.7% and total debt fell 9.93%, each against the same quarter a year earlier.

25.74 0.25 +0.98%
Market cap
$24.9B
P/E
18.8×
Fwd P/E
11.2×
Dividend yield
3.94%
F-score
7/9
Altman Z
1.98
Beneish M
−2.68
Dividend safety
55/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
19.86 22.85 24.87 33.65

+8 more quarters

P/S ratio
1.26 1.28 1.27 1.36
P/FCF ratio
14.05 14.78 44.24 0.00
P/Operating CF
59.63 118.50 16.23 71.24
P/B ratio
1.95 1.95 2.07 2.10
EV/Sales
1.51 1.52 1.50 1.68
EV/EBITDA
9.19 10.26 10.50 11.16
EV/FCF
16.85 17.59 52.15 (25.95)
Current Ratio
1.26 1.32 1.32 1.32
Net Debt/EBITDA
4.51 8.34 5.15 8.10
Debt/Equity
0.55 0.60 0.63 0.68
Earnings Yield
5.03% 4.38% 4.02% 2.97%
Free Cash Flow Yield
7.12% 6.76% 2.26% (4.76%)
Free Cash Flow per Share
0.27 0.03 1.46 0.18
Book value per Share
13.96 14.04 13.11 13.01
Free Cash Flow
259.07 32.77 1,384.61 173.20
EV/EBIT
15.71 17.93 18.79 23.31
Other line items

Show all line items

Columns are period end dates